Visit the AHRP blog:
http://ahrp.blogspot.com

Top News
Hearing: Americans Denied Human Right to Say NO to Experimental Research Under FDA Rule
Wednesday, 11 October 2006

Tomorrow Hearing  FDA’s Emergency Research Rule--CNN News at 8:00 P.M will inform the public about how the FDA Rule impacts on American citizens who can be put at increased risk to test an experimental treatment without their knowledge or consent.

Read more...
 
FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
Monday, 09 October 2006

Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.

Read more...
 
Industry Influence: FDA "Critical Path"/ Biased Research: BMJ / NIH: still smoke & mirrors
Saturday, 07 October 2006
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders--the pharmaceutical-academic industrial complex.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 33 - 36 of 82
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]